IGFBP7 is upregulated in the prefrontal cortex of AD patients, perhaps indicating that the AD‐associated reduction in brain IGF2 signaling may stem not only from reduced expression but also from increased sequestration of extracellular IGF2.107, 127. Here, IGFBP7 is linked to Alzheimer disease.